ECSP11004868A - Capsulas para inhalación - Google Patents

Capsulas para inhalación

Info

Publication number
ECSP11004868A
ECSP11004868A EC2011004868A ECSP11004868A ECSP11004868A EC SP11004868 A ECSP11004868 A EC SP11004868A EC 2011004868 A EC2011004868 A EC 2011004868A EC SP11004868 A ECSP11004868 A EC SP11004868A EC SP11004868 A ECSP11004868 A EC SP11004868A
Authority
EC
Ecuador
Prior art keywords
inhalation capsules
inhalation
capsules
inhalets
active ingredient
Prior art date
Application number
EC2011004868A
Other languages
English (en)
Inventor
Michael Trunk
Michael Walz
Dieter Hochrainer
Karoline Bechtold-Peters
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7687020&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP11004868(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of ECSP11004868A publication Critical patent/ECSP11004868A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A61M11/003—Particle size control by passing the aerosol trough sieves or filters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0028—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
    • A61M15/003—Inhalators using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up using capsules, e.g. to be perforated or broken-up
    • A61M15/0033—Details of the piercing or cutting means
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Abstract

La invención se refiere a cápsulas de inhalación (inhaletas) hechas a base de un material capsular específico con el contenido de humedad reducido, que contienen tiotropio como ingrediente activo en forma de un preparado en polvo y se caracteriza por una estabilidad mejorada.
EC2011004868A 2001-06-01 2011-01-06 Capsulas para inhalación ECSP11004868A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10126924A DE10126924A1 (de) 2001-06-01 2001-06-01 Inhalationskapseln

Publications (1)

Publication Number Publication Date
ECSP11004868A true ECSP11004868A (es) 2011-02-28

Family

ID=7687020

Family Applications (2)

Application Number Title Priority Date Filing Date
EC2003004868A ECSP034868A (es) 2001-06-01 2003-11-27 Cápsulas para inhalación
EC2011004868A ECSP11004868A (es) 2001-06-01 2011-01-06 Capsulas para inhalación

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EC2003004868A ECSP034868A (es) 2001-06-01 2003-11-27 Cápsulas para inhalación

Country Status (37)

Country Link
EP (2) EP1379220B1 (es)
JP (3) JP4447311B2 (es)
KR (2) KR100921904B1 (es)
CN (3) CN1512875A (es)
AR (2) AR034346A1 (es)
AT (1) ATE285752T1 (es)
AU (2) AU2002344354B2 (es)
BG (1) BG65655B1 (es)
BR (1) BR0209366A (es)
CA (1) CA2448425C (es)
CH (1) CH1379220H1 (es)
CO (1) CO5540379A2 (es)
CZ (1) CZ300284B6 (es)
DE (2) DE10126924A1 (es)
EA (1) EA005188B1 (es)
EC (2) ECSP034868A (es)
EE (1) EE05416B1 (es)
EG (1) EG24227A (es)
ES (1) ES2236590B5 (es)
HR (1) HRP20030993B1 (es)
HU (3) HU230058B1 (es)
IL (2) IL158917A0 (es)
ME (1) ME00301B (es)
MX (1) MXPA03010990A (es)
MY (1) MY126253A (es)
NO (1) NO332857B3 (es)
NZ (1) NZ530356A (es)
PE (1) PE20030071A1 (es)
PL (2) PL205714B1 (es)
PT (1) PT1379220E (es)
RS (1) RS50353B (es)
SI (1) SI1379220T1 (es)
SK (2) SK287346B6 (es)
TW (1) TWI327921B (es)
UA (1) UA75659C2 (es)
WO (1) WO2002098874A2 (es)
ZA (1) ZA200308340B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50103551C5 (de) 2000-10-12 2014-08-21 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue tiotropium-haltige inhalationspulver
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln
DE10212264A1 (de) 2002-03-20 2003-10-02 Boehringer Ingelheim Pharma Kristallines Mikronisat, Verfahren zu dessen Herstellung und dessen Verwendung zur Herstellung eines Arzneimittels
WO2003094890A1 (en) * 2002-05-07 2003-11-20 Nektar Therapeutics Capsules for dry powder inhalers and methods of making and using same
US7763280B2 (en) 2002-11-28 2010-07-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tiotropium containing powder formulation for inhalation
DE10255387A1 (de) * 2002-11-28 2004-06-09 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Tiotropium-haltige Pulverformulierung für die Inhalation
DE10258360A1 (de) * 2002-12-12 2004-06-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator mit Kapselkammer zum Aufnehmen einer mit Wirkstoff gefüllten Einwegkapsel
DE10352277A1 (de) * 2003-11-08 2005-06-02 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
SE0303570L (sv) 2003-12-03 2005-06-04 Microdrug Ag Fukt-känslig medicinsk produkt
SE0303269L (sv) * 2003-12-03 2005-06-04 Microdrug Ag Medicinsk produkt
GB0503738D0 (en) 2005-02-23 2005-03-30 Optinose As Powder delivery devices
US7694676B2 (en) 2005-04-22 2010-04-13 Boehringer Ingelheim Gmbh Dry powder inhaler
JP4825455B2 (ja) * 2005-05-02 2011-11-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 粉末吸入器
DE102006016904A1 (de) 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalator
DE102006016901A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Mundstück für einen Inhalator
GB0716026D0 (en) * 2007-08-16 2007-09-26 Norton Healthcare Ltd An inhalable medicament
DE102007036411A1 (de) 2007-07-20 2009-02-12 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pulverinhalator
DE102007052871A1 (de) * 2007-11-02 2009-05-07 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kapsel zur Aufnahme von pharmazeutischen Wirkstoffformulierungen
US20100327476A1 (en) * 2008-02-08 2010-12-30 Boehringer Ingelheim International Gmbh Method and device for filling capsules
EP2172190A1 (en) * 2008-10-02 2010-04-07 Laboratorios Liconsa, S.A. Inhalable particles comprising tiotropium
DK2400950T3 (da) 2009-02-26 2019-07-29 Glaxo Group Ltd Farmaceutiske formuleringer omfattende 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
WO2010110760A1 (en) * 2009-03-27 2010-09-30 Mahmut Bilgic Compositions comprising water with deuterium for the prevention or treatment of allergic diseases and a process for the preparation thereof
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
US9259376B2 (en) 2010-06-03 2016-02-16 Sima Patent Ve Lisanslama Hizmetleri Ltd. Sti. Process for dry powder formulations
DE202011102694U1 (de) 2011-06-29 2011-12-19 Zisser Gmbh Inhalationsgerät für Heimanwender
GB201200525D0 (en) 2011-12-19 2012-02-29 Teva Branded Pharmaceutical Prod R & D Inc An inhalable medicament
UA115989C2 (uk) 2012-07-05 2018-01-25 Арвен Айлак Санайі Ве Тіджарет А.С. Фармацевтична композиція для інгалятора сухого порошку, що містить антагоністи мускаринових рецепторів тривалої дії
DE202013000774U1 (de) 2013-01-21 2013-04-15 Rhinofilt GmbH Miniaturisiertes Inhalationsgerät zur Privatanwendung
US10034866B2 (en) 2014-06-19 2018-07-31 Teva Branded Pharmaceutical Products R&D, Inc. Inhalable medicament comprising tiotropium
CN108295042A (zh) * 2018-03-05 2018-07-20 上海祺宇生物科技有限公司 一种用于吸入药剂的植物空心胶囊及其胶囊剂
CN108451920A (zh) * 2018-03-14 2018-08-28 绍兴康可胶囊有限公司 一种吸雾式胶囊及其制备方法
CN114848605B (zh) * 2022-03-25 2023-08-11 上海方予健康医药科技有限公司 一种供吸入粉雾剂用的明胶胶囊

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931041C2 (de) * 1989-09-16 2000-04-06 Boehringer Ingelheim Kg Ester von Thienylcarbonsäuren mit Aminoalkoholen, ihre Quaternierungsprodukte, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AU660824B2 (en) * 1992-06-12 1995-07-06 Teijin Limited Pharmaceutical preparation for intra-airway administration
US6228394B1 (en) * 1997-10-14 2001-05-08 Boehringer Ingelheim Pharmaceuticals, Inc. Supercritical fluid extraction of mould lubricant from hard shell capsules
DE19835346A1 (de) * 1998-08-05 2000-02-10 Boehringer Ingelheim Pharma Zweiteilige Kapsel zur Aufnahme von pharmazeutischen Zubereitungen für Pulverinhalatoren
JP2000143502A (ja) * 1998-11-11 2000-05-23 Shionogi Qualicaps Kk 吸入製剤
DK1283036T3 (da) * 1998-11-13 2008-03-25 Jagotec Ag Törpulver til inhalation
DE19921693A1 (de) * 1999-05-12 2000-11-16 Boehringer Ingelheim Pharma Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
EP1072258A1 (de) * 1999-07-28 2001-01-31 Greither, Peter Eine Kapsel für die Freisetzung von Bakterien, enthaltend ein Bakterienlyophilisat und ein Verfahren zu ihrer Herstellung
EP1238661A1 (en) * 1999-10-12 2002-09-11 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DE10126924A1 (de) * 2001-06-01 2002-12-05 Boehringer Ingelheim Pharma Inhalationskapseln

Also Published As

Publication number Publication date
EG24227A (en) 2008-11-10
NO332857B1 (no) 2013-01-21
BR0209366A (pt) 2004-06-08
AU2008203057C1 (en) 2017-05-18
MEP42508A (en) 2011-02-10
ME00301B (me) 2011-05-10
HU230827B1 (hu) 2018-07-30
SK287346B6 (sk) 2010-07-07
CH1379220H1 (es) 2018-10-31
ES2236590T3 (es) 2005-07-16
NO332857B3 (no) 2016-01-25
PL387118A1 (pl) 2004-12-13
UA75659C2 (en) 2006-05-15
CN101829072A (zh) 2010-09-15
AR034346A1 (es) 2004-02-18
HUP1500188A2 (en) 2005-03-29
HUP0400666A2 (hu) 2005-03-29
CN1512875A (zh) 2004-07-14
DE10126924A1 (de) 2002-12-05
DE50201898D1 (de) 2005-02-03
IL158917A (en) 2008-11-03
RS50353B (sr) 2009-11-10
CZ20033579A3 (en) 2004-05-12
KR20040007638A (ko) 2004-01-24
ECSP034868A (es) 2004-03-23
MXPA03010990A (es) 2004-02-27
HUP0400666A3 (en) 2009-06-29
PL205714B1 (pl) 2010-05-31
AU2008203057C8 (en) 2017-04-06
JP4787034B2 (ja) 2011-10-05
EE05416B1 (et) 2011-06-15
HRP20030993A2 (en) 2005-08-31
JP2005500279A (ja) 2005-01-06
HU231082B1 (hu) 2020-06-29
EE200300595A (et) 2004-02-16
BG65655B1 (bg) 2009-05-29
EA005188B1 (ru) 2004-12-30
PL203801B1 (pl) 2009-11-30
PL364108A1 (en) 2004-12-13
KR100921904B1 (ko) 2009-10-16
CN101697965A (zh) 2010-04-28
KR100952321B1 (ko) 2010-04-09
BG108380A (en) 2004-11-30
EP1379220B1 (de) 2004-12-29
NO20035265L (no) 2003-11-27
CO5540379A2 (es) 2005-07-29
TWI327921B (en) 2010-08-01
ZA200308340B (en) 2004-05-21
WO2002098874A3 (de) 2003-09-12
IL158917A0 (en) 2004-05-12
SK287379B6 (sk) 2010-08-09
JP2006143747A (ja) 2006-06-08
AR084804A2 (es) 2013-06-26
JP4447311B2 (ja) 2010-04-07
CZ300284B6 (cs) 2009-04-08
EP1379220A2 (de) 2004-01-14
JP2008050364A (ja) 2008-03-06
KR20090010140A (ko) 2009-01-28
AU2008203057A1 (en) 2008-07-31
NO20035265D0 (no) 2003-11-27
CA2448425C (en) 2010-12-21
ATE285752T1 (de) 2005-01-15
CA2448425A1 (en) 2002-12-12
EA200301275A1 (ru) 2004-06-24
YU93503A (sh) 2006-05-25
SI1379220T1 (en) 2005-04-30
HU230058B1 (hu) 2015-06-29
MY126253A (en) 2006-09-29
EP1508330A1 (de) 2005-02-23
HRP20030993B1 (en) 2011-10-31
NZ530356A (en) 2005-05-27
PE20030071A1 (es) 2003-03-04
WO2002098874A2 (de) 2002-12-12
ES2236590B5 (es) 2018-03-05
PT1379220E (pt) 2005-03-31
SK16202003A3 (sk) 2004-05-04
AU2002344354B2 (en) 2008-08-07
AU2008203057B2 (en) 2011-12-08

Similar Documents

Publication Publication Date Title
ECSP11004868A (es) Capsulas para inhalación
WO2005097076A3 (en) Low dose pharmaceutical products
TW200716206A (en) Unitary pharmaceutical dosage form
AR109263A2 (es) Composición que comprende moxidectina
EA200701655A1 (ru) Материалы для доставки лекарств, полученные золь-гелевым методом
AR049083A1 (es) Proceso para la preparacion de una forma de dosificacion solida a prueba de abuso
CL2010000816A1 (es) Formulacion adecuada para administracion subcutanea que comprende al menos 100 mg/ml de ctlaig, un azucar, y un portador acuoso farmaceuticamente estable; articulo de fabricacion que comprende al menos un recipiente que contiene la formulacion antes mencionada. (divisional solicitud n° 3597-06)
TW200633716A (en) Compositions and methods for stabilizing active pharmaceutical ingredients
DK1883400T3 (da) Kapsler til inhalatorer
MXPA05002942A (es) Forma de dosificacion oral de liberacion modificada.
ECSP034826A (es) Método para fabricar una composición farmacéutica de dosis baja
EE05723B1 (et) Stabiilse koostisega ravimkoostis, mis sisaldab amlodipiini ja bisoprolooli, ning meetod selle valmistamiseks
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
DK1858494T3 (da) Hidtil ukendte blöde gelatinekapsler
EA200701805A1 (ru) Состав аэрозоля для дозирующих ингаляторов под давлением
ES2325291A1 (es) "uso de un extracto de silybum marianum"
ITMI20022549A1 (it) Composizione quaternaria comprendente come sostanza attiva la propolis.
SE0000303D0 (sv) Novel compounds
SE0303135D0 (sv) Controlled food effect composition
UY27314A1 (es) Capsulas para inhalación
ATE471712T1 (de) Pharmazeutische zusammensetzung mit tetrahydrolipstatin
AR029718A1 (es) Composicion farmaceutica a base de cocaetileno y su utilizacion para el tratamiento de la dependencia de las substancias psicoactivas
ECSP045039A (es) Composiciones de disgregación intraoral organolepticamente aceptables
UY28199A1 (es) Nuevas composiciones antihelmínticas e insecticidas
PA8616401A1 (es) Formulaciones farmaceuticas